- Home
- ELVN vs CAL Comparison
ELVN vs CAL Comparison
Compare ELVN & CAL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ELVN
- CAL
- Stock Information
- Founded
- ELVN 2016
- CAL 1878
- Country
- ELVN United States
- CAL United States
- Employees
- ELVN N/A
- CAL N/A
- Industry
- ELVN Biotechnology: Pharmaceutical Preparations
- CAL Shoe Manufacturing
- Sector
- ELVN Health Care
- CAL Consumer Discretionary
- Exchange
- ELVN Nasdaq
- CAL Nasdaq
- Market Cap
- ELVN 927.8M
- CAL 520.3M
- IPO Year
- ELVN 2020
- CAL N/A
- Fundamental
- Price
- ELVN $20.73
- CAL $14.03
- Analyst Decision
- ELVN Strong Buy
- CAL Hold
- Analyst Count
- ELVN 5
- CAL 1
- Target Price
- ELVN $41.20
- CAL $14.00
- AVG Volume (30 Days)
- ELVN 734.1K
- CAL 1.0M
- Earning Date
- ELVN 08-12-2025
- CAL 05-29-2025
- Dividend Yield
- ELVN N/A
- CAL 2.02%
- EPS Growth
- ELVN N/A
- CAL N/A
- EPS
- ELVN N/A
- CAL 2.43
- Revenue
- ELVN N/A
- CAL $2,677,706,000.00
- Revenue This Year
- ELVN N/A
- CAL N/A
- Revenue Next Year
- ELVN N/A
- CAL $3.48
- P/E Ratio
- ELVN N/A
- CAL $5.78
- Revenue Growth
- ELVN N/A
- CAL N/A
- 52 Week Low
- ELVN $13.30
- CAL $12.09
- 52 Week High
- ELVN $30.03
- CAL $44.51
- Technical
- Relative Strength Index (RSI)
- ELVN 52.36
- CAL 52.67
- Support Level
- ELVN $19.22
- CAL $12.14
- Resistance Level
- ELVN $21.90
- CAL $12.83
- Average True Range (ATR)
- ELVN 1.46
- CAL 0.68
- MACD
- ELVN -0.19
- CAL 0.21
- Stochastic Oscillator
- ELVN 40.50
- CAL 93.75
About ELVN Enliven Therapeutics Inc.
Enliven Therapeutics Inc is a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics. Its product candidates include ELVN-001 is designed to specifically target the BCR-ABL fusion gene product, the oncogenic driver for patients with chronic myeloid leukemia (CML), ELVN-002 is designed to inhibit wild-type HER2 and key mutations of HER2.
About CAL Caleres Inc.
Caleres Inc is a footwear company that operates retail shoe stores and e-commerce websites, and designs, develops, sources, manufactures, and distributes footwear for people of all ages. The Company's business operations are organized into two reportable segments - famous Footwear and Brand Portfolio. The famous Footwear segment is comprised of its famous Footwear retail stores, famousfootwear.com, and famousfootwear.ca. The famous Footwear segment operated around 846 stores at the end of 2024. The Brand Portfolio segment offers retailers and consumers a cultivated portfolio of known brands. Geographically, the company generates the majority of its revenue from Domestic operations.